QBio · Ethical sourcing
What is not in the vial matters.
Traceability starts before manufacturing.
Qualified U.S. cord-bank partners, donor eligibility review, and a visible infectious-disease screening panel form the first layer of the QBio quality system.
Origin standard
Qualified U.S. partners. Clear eligibility criteria.
Inputs are sourced through AABB-accredited, FDA-registered cord-bank partners from live, healthy, full-term scheduled C-section births in U.S. hospitals, with no harm to mother or newborn.
Infectious-disease screening
The full panel, not a summary.
The donor-screening panel is reviewed as part of eligibility determination before release. Abbreviations are retained to match laboratory and regulatory documentation.
01West Nile virus (WNV)
02Chagas
03Hepatitis B core antibody (HBcAb)
04Hepatitis B surface antigen (HBsAg)
05HBV NAT
06HCV antibody
07HCV NAT
08HIV-1/2 antibody
09HIV NAT
10HTLV-I/II
11Syphilis (STS)
12CMV
13Zika
Eligibility review
Release follows review, not assumption.
Donor eligibility is reviewed under the applicable screening and record requirements before qualified material advances into the manufacturing process.
PARTNER QUALIFICATIONDONOR HISTORYINFECTIOUS-DISEASE PANELELIGIBILITY DETERMINATION